Evidence map›Paper›PMID 38262919›Full record

ArticleBMC plant biology2024

Genomic characterization of WRKY transcription factors related to secoiridoid biosynthesis in Gentiana macrophylla.

Yangyang Yin, Huanhuan Fu, Fakai Mi, Ye Yang, Yaomin Wang, Zhe Li, Yihan He, Zhenggang Yue

Open access · goldAbstract read
In one paragraph

Article in BMC plant biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
6.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Evolution of theInternational journal of molecular sciences · 2024
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yangyang YinState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Coconstruction Collaborative Innovation Center for Chinese Medicinal Resources Industrialization By Shaanxi & Education Ministry, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Huanhuan FuState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Coconstruction Collaborative Innovation Center for Chinese Medicinal Resources Industrialization By Shaanxi & Education Ministry, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Fakai MiCollege of Life Science, Qinghai Normal University, Xining, 810016, People's Republic of China.
Ye YangState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Coconstruction Collaborative Innovation Center for Chinese Medicinal Resources Industrialization By Shaanxi & Education Ministry, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Yaomin WangState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Coconstruction Collaborative Innovation Center for Chinese Medicinal Resources Industrialization By Shaanxi & Education Ministry, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Zhe LiState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Coconstruction Collaborative Innovation Center for Chinese Medicinal Resources Industrialization By Shaanxi & Education Ministry, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China.
Yihan HeState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Coconstruction Collaborative Innovation Center for Chinese Medicinal Resources Industrialization By Shaanxi & Education Ministry, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China. annaaid@126.com.
Zhenggang YueState Key Laboratory of Research & Development of Characteristic Qin Medicine Resources (Cultivation), Coconstruction Collaborative Innovation Center for Chinese Medicinal Resources Industrialization By Shaanxi & Education Ministry, Shaanxi Innovative Drug Research Center, School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang, 712046, People's Republic of China. liuxingjian1981@163.com.
Shaanxi University of Chinese Medicine · CNQinghai Normal University · CN

Funding

Natural Science Foundation of China 81503237Natural Science Foundation of China 81903753
6 · The paper itself

Abstract

Gentiana macrophylla is one of Chinese herbal medicines in which 4 kinds of iridoids or secoiridoids, such as loganic acid, sweroside, swertiamarin, and gentiopicroside, are identified as the dominant medicinal secondary metabolites. WRKY, as a large family of transcription factors (TFs), plays an important role in the synthesis of secondary metabolites in plants. Therefore, WRKY genes involved in the biosynthesis of secoiridoids in G. macrophylla were systematically studied. First, a comprehensive genome-wide analysis was performed, and 42 GmWRKY genes were identified, which were unevenly distributed in 12 chromosomes. Accordingly, gene structure, collinearity, sequence alignment, phylogenetic, conserved motif and promoter analyses were performed, and the GmWRKY proteins were divided into three subfamilies based on phylogenetic and multiple sequence alignment analyses. Moreover, the enzyme-encoding genes of the secoiridoid biosynthesis pathway and their promoters were then analysed, and the contents of the four secoiridoids were determined in different tissues. Accordingly, correlation analysis was performed using Pearson's correlation coefficient to construct WRKY gene-enzyme-encoding genes and WRKY gene-metabolite networks. Meanwhile, G. macrophylla seedlings were treated with methyl jasmonate (MeJA) to detect the dynamic change trend of GmWRKYs, biosynthetic genes, and medicinal ingredient accumulation. Thus, a total of 12 GmWRKYs were identified to be involved in the biosynthesis of secoiridoids, of which 8 (GmWRKY1, 6, 12, 17, 33, 34, 38 and 39) were found to regulate the synthesis of gentiopicroside, and 4 (GmWRKY7, 14, 26 and 41) were found to regulate the synthesis of loganic acid. Taken together, this study systematically identified WRKY transcription factors related to the biosynthesis of secoiridoids in G. macrophylla, which could be used as a cue for further investigation of WRKY gene functions in secondary metabolite accumulation.

Indexed as

GentianaIridoid GlucosidesGenomicsIridoidsPhylogenyTranscription FactorsgentiopicrosideIridoid GlucosidesIridoidsloganic acidTranscription FactorsCorrelation analysisGentiana macrophyllaMethyl jasmonate treatmentSecoiridoid biosynthesisWRKY transcription factors

Identifiers

PMID38262919
PMCPMC10804491
OpenAlexW4391137474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.